191 related articles for article (PubMed ID: 32146600)
21. Optimistic bias, advertising skepticism, and consumer intentions for seeking information about the health risks of prescription medicine.
Park JS; Ahn HA; Haley EJ
Health Mark Q; 2017; 34(2):81-96. PubMed ID: 28590885
[TBL] [Abstract][Full Text] [Related]
22. African American patients' attitudes toward proactive health behaviors after exposure to direct-to-consumer advertising.
Yang Y; Gourley DR; Gourley GA; Faris RJ; Womeodu RJ; Yang J; Likens CC
J Natl Med Assoc; 2010 May; 102(5):408-15. PubMed ID: 20533776
[TBL] [Abstract][Full Text] [Related]
23. Effects of conflicting prescription drug information from direct-to-consumer advertising and drug injury advertising on patients' beliefs and medication adherence.
Im H; Huh J
Res Social Adm Pharm; 2022 Jul; 18(7):3119-3130. PubMed ID: 34454872
[TBL] [Abstract][Full Text] [Related]
24. Optimistic Bias and Consumer Prescription Drug Decisions: Influences of Direct to Consumer Advertising and Perceived Susceptibility.
Ju I; Park T; Ohs J
Health Commun; 2022 Nov; 37(13):1694-1703. PubMed ID: 33899598
[TBL] [Abstract][Full Text] [Related]
25. Living with inflammatory bowel disease: A Crohn's and Colitis Canada survey.
Becker HM; Grigat D; Ghosh S; Kaplan GG; Dieleman L; Wine E; Fedorak RN; Fernandes A; Panaccione R; Barkema HW
Can J Gastroenterol Hepatol; 2015 Mar; 29(2):77-84. PubMed ID: 25803017
[TBL] [Abstract][Full Text] [Related]
26. Introduction of direct-to-consumer advertising of prescription drugs in Canada: an opinion survey on regulatory policy.
Mintzes B; Barer M; Lexchin J; Bassett KL
Res Social Adm Pharm; 2005 Jun; 1(2):310-30. PubMed ID: 17138480
[TBL] [Abstract][Full Text] [Related]
27. Predicting Pre-emptive Discussions of Biologic Treatment: Results from an Openness and Preference Survey of Inflammatory Bowel Disease Patients and Their Prescribers.
Kariburyo MF; Xie L; Teeple A; Tan H; Ingham M
Adv Ther; 2017 Jun; 34(6):1398-1410. PubMed ID: 28484953
[TBL] [Abstract][Full Text] [Related]
28. The effect of competing direct-to-consumer advertising campaigns on the use of drugs for benign prostatic hyperplasia: time series analysis.
Skeldon SC; Kozhimannil KB; Majumdar SR; Law MR
J Gen Intern Med; 2015 Apr; 30(4):514-20. PubMed ID: 25338730
[TBL] [Abstract][Full Text] [Related]
29. Effects of risk disclosure prominence in direct-to-consumer advertising (DTCA) of prescription drugs: An integrative cognitive process model.
Ju I; Park JS
Health Mark Q; 2018; 35(1):32-46. PubMed ID: 29608136
[TBL] [Abstract][Full Text] [Related]
30. Direct-to-consumer advertising (DTCA) for prescription drugs: consumers' attitudes and preferences concerning its regulation in South Korea.
Suh HS; Lee D; Kim SY; Chee DH; Kang HY
Health Policy; 2011 Aug; 101(3):260-8. PubMed ID: 21705104
[TBL] [Abstract][Full Text] [Related]
31. Direct-to-Consumer Advertising of Prescription Drugs and the Patient-Prescriber Encounter: A Systematic Review.
DeFrank JT; Berkman ND; Kahwati L; Cullen K; Aikin KJ; Sullivan HW
Health Commun; 2020 May; 35(6):739-746. PubMed ID: 30973021
[TBL] [Abstract][Full Text] [Related]
32. Patient awareness of extraintestinal manifestations of inflammatory bowel disease.
Huang V; Mishra R; Thanabalan R; Nguyen GC
J Crohns Colitis; 2013 Sep; 7(8):e318-24. PubMed ID: 23265763
[TBL] [Abstract][Full Text] [Related]
33. Consumers' knowledge, perceptions, and responsiveness to direct-to-consumer advertising of prescription medicines.
Hoek J; Maubach N
N Z Med J; 2007 Feb; 120(1249):U2425. PubMed ID: 17308562
[TBL] [Abstract][Full Text] [Related]
34. Trends in direct-to-consumer advertising of prescription contraceptives.
Wu MH; Bartz D; Avorn J; Seeger JD
Contraception; 2016 May; 93(5):398-405. PubMed ID: 26808088
[TBL] [Abstract][Full Text] [Related]
35. Physicians report on patient encounters involving direct-to-consumer advertising.
Weissman JS; Blumenthal D; Silk AJ; Newman M; Zapert K; Leitman R; Feibelmann S
Health Aff (Millwood); 2004; Suppl Web Exclusives():W4-219-33. PubMed ID: 15452007
[TBL] [Abstract][Full Text] [Related]
36. Influence on consumer behavior: the impact of direct-to-consumer advertising on medication requests for gastroesophageal reflux disease and social anxiety disorder.
Khanfar NM; Polen HH; Clauson KA
J Health Commun; 2009; 14(5):451-60. PubMed ID: 19657925
[TBL] [Abstract][Full Text] [Related]
37. Impact of direct-to-consumer drug advertising during the Super Bowl on drug utilization.
Gray MP; San-Juan-Rodriguez A; Chen N; Good CB; Hernandez I
Res Social Adm Pharm; 2020 Aug; 16(8):1136-1139. PubMed ID: 31864886
[TBL] [Abstract][Full Text] [Related]
38. A Study of the Frequency and Social Determinants of Exposure to Cancer-Related Direct-to-Consumer Advertising Among Breast, Prostate, and Colorectal Cancer Patients.
Tan AS
Health Commun; 2015; 30(11):1102-11. PubMed ID: 25357119
[TBL] [Abstract][Full Text] [Related]
39. Pharmacy students' opinions of direct-to-consumer advertising: a pilot study at one university.
Harrington AR; Desselle SP; Apgar DA; Hesselbacher E; Pié A; Quesnel A; Warholak TL
Res Social Adm Pharm; 2013; 9(4):458-66. PubMed ID: 22999802
[TBL] [Abstract][Full Text] [Related]
40. Effects of exposure to direct-to-consumer television advertising for statin drugs on food and exercise guilt.
Kruger C; Niederdeppe J; Byrne S; Avery RJ
Patient Educ Couns; 2015 Sep; 98(9):1150-5. PubMed ID: 26100034
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
